Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06783049
NA

Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent Management System

Sponsor: Beijing Tiantan Hospital

View on ClinicalTrials.gov

Summary

The purpose of this study is to develop a digital health-based intelligent management system for the secondary prevention of ischemic stroke and to evaluate its effectiveness through a multicenter randomized controlled trial, assessing its health economic value. Participants will receive usual care after discharge (control group) or be managed with a WeChat-based intelligent management system after discharge (intervention group). At one year, all patients will undergo face-to-face follow-up to assess clinical events, medication adherence, and the achievement of target risk factor levels.

Official title: Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack With an Intelligent System

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

4490

Start Date

2025-03-03

Completion Date

2027-01-31

Last Updated

2026-01-21

Healthy Volunteers

No

Interventions

BEHAVIORAL

Cerebrovascular Disease Secondary Prevention Smart Management System

The continuous post-discharge intervention for patients was conducted using the Cerebrovascular Disease Secondary Prevention Smart Management System. This system, integrated with a WeChat-based applet, records patients' basic information and connects with mobile IoT devices such as blood pressure monitors and glucose meters. This allows patients to self-monitor their risk factors post-discharge. Based on international guidelines, high-level evidence, and the clinical expertise of cerebrovascular specialists, a comprehensive clinical decision-making tree was developed. This serves as the foundation for an AI feedback system that provides intelligent feedback on risk factor control and predicts the risk of recurrence.

Locations (3)

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, China

The First Affiliated Hospital of Shihezi University

Shihezi, Xinjiang, China

Beijing Tiantan Hospital

Beijing, China